Bristol-Myers Squibb - 10% downside potential
When I see a stock go from 2.6 times sales to 6.4 times sales while revenues have fallen from $21 billion to $16 billion, you can tell that investors are hoping for something big coming down the road.
For now, I'll look for a trip down to the lower end of the rising regression channel.
Risk - $64 or $65. Target $53-$54.
Tim 4:25PM EST Feb 27, 2015
For now, I'll look for a trip down to the lower end of the rising regression channel.
Risk - $64 or $65. Target $53-$54.
Tim 4:25PM EST Feb 27, 2015
Subscribe to my indicator package KEY HIDDEN LEVELS $20/mo or a discount for a year and join in the trading room KEY HIDDEN LEVELS here at TradingView.com
timwest
BMY keeps chugging along in the uptrend channel, defying gravity and the logic of valuation. Buyers must know something we don't or else watch out below. 67.55 last, July 6, 2015. 3:31PM EST
Reply
2use
I bet it gets down with the looming market correction
+1
Reply
IvanLabrie
This is really great Tim...Definitely a great opportunity.
+1
Reply